Alecensa 150 mg, Hartkapseln

7680659700013 CH-65970 Kapseln

Associated product:

ALECENSA gél 150 mg 224 pce
Alecensa 150 mg, Hartkapseln
Alecensa 150 mg, Hartkapseln
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
224
Selling units
224
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
10/09/2026
Summary of Product Characteristics
Français
10/09/2026
Summary of Product Characteristics
Italien
10/09/2026
Patient information leaflet
Allemand
16/06/2026
Patient information leaflet
Français
16/06/2026
Patient information leaflet
Italien
16/06/2026

Detailed composition

Substance Quantity Type Category
alectinibum
150.0 MG Substance Wirkstoff (Principe actif)
alectinibi hydrochloridum
- Substance WIZUS
lactosum monohydricum
33.67 MG Substance HBESI
hydroxypropylcellulosum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
6.0 MG Substance HBESI
carmellosum calcicum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
carrageenanum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
E 171
- Substance FNIDK
cera carnauba
- Substance HNIDK
maydis amylum
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 132
- Substance FIMDK
cera carnauba
- Substance HNIDK
lacca
- Substance HNIDK
polyglyceroli-3 mono-oleas
- Substance HNIDK

Reimbursement information

Public price
CHF 4741.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2017

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
65970
Drug name
Alecensa, Hartkapseln
Galenic form
KAHA
ATC Code
L01ED03
Authorization status
Z
Dispensing category
A
First authorization
26/01/2017
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
nicht-kleinzelliges Lungenkarzinom (NSCLC)

Package details

Description (FR)
ALECENSA gél 150 mg 224 pce
Description (DE)
ALECENSA Kaps 150 mg 224 Stk
Market launch
26/01/2017
Narcotic (BTM)
No
Buy us a coffee Explore the data